Bioatla
Price & Volume
Stats
See more52W Range | $0.24-$4.02 |
Market Cap | $20M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $11M |
Revenue Growth (YoY) | 31.6% |
Gross Profit (12 Mos) | -$63.1M |
Diluted EPS | -$1.70 |
News
See moreYahoo Finance • 5 months ago
BioAtla, Inc. (BCAB): Among Michael Burry’s Top 10 Stock Picks Heading Into 2025
Yahoo Finance • last year
After losing 78% in the past year, BioAtla, Inc. (NASDAQ:BCAB) institutional owners must be relieved by the recent gain
Yahoo Finance • last year
BioAtla to Host Virtual R&D Day to Review BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types on Wednesday, December 13, 2023
Yahoo Finance • last year
BioAtla to Participate in the JMP Securities Hematology and Oncology Summit
About
CEO | Dr. Jay M. Short Ph.D. |
CFO | Mr. Richard A. Waldron |
Address | 11085 Torreyana Road, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 65 |
